# Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-scp-iii-scp-study-of-gemcitabine-cisplatin-plus-s-1-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tatsuya Ioka,Masashi Kanai,Shogo Kobayashi,Daisuke Sakai,Hidetoshi Eguchi,Hideo Baba,Satoru Seo,Akinobu Taketomi,Tadatoshi Takayama,Hiroki Yamaue,Masahiro Takahashi,Masayuki Sho,Keiko Kamei,Jiro Fujimoto,Masanori Toyoda,Junzo Shimizu,Takuma Goto,Yoshitaro Shindo,Kenichi Yoshimura,Etsuro Hatano,Hiroaki Nagano,Kansai Hepatobiliary Oncology Group (KHBO) |
| Citations | 240 |
| DOI | 10.1002/jhbp.1219 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jhbp.1219 |
| OpenAlex ID | https://openalex.org/W4288425344 |
| PMID | 35900311 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Hidetoshi Eguchi](https://scholariq.org/researchers/hidetoshi-eguchi/)

## Paper primary topic

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Paper topics

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.